<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32803350</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0533</ISSN><JournalIssue CitedMedium="Internet"><Volume>140</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Acta neuropathologica</Title><ISOAbbreviation>Acta Neuropathol</ISOAbbreviation></Journal><ArticleTitle>TDP-43 transports ribosomal protein mRNA to regulate axonal local translation in neuronal axons.</ArticleTitle><Pagination><StartPage>695</StartPage><EndPage>713</EndPage><MedlinePgn>695-713</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00401-020-02205-y</ELocationID><Abstract><AbstractText>Mislocalization and abnormal deposition of TDP-43 into the cytoplasm (TDP-43 proteinopathy) is a hallmark in neurons of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). However, the pathogenic mechanism of the diseases linked to TDP-43 is largely unknown. We hypothesized that the failure of mRNA transport to neuronal axons by TDP-43 may contribute to neurodegeneration in ALS and FTLD, and sought to examine the function of TDP-43 by identifying its target mRNA for axonal transport. We found that mRNAs related to translational function including ribosomal proteins (RPs) were decreased by shRNA-based TDP-43 knock-down in neurites of cortical neurons. TDP-43 binds to and transports the RP mRNAs through their 5' untranslated region, which contains a common 5' terminal oligopyrimidine tract motif and a downstream GC-rich region. We showed by employing in vitro and in vivo models that the RP mRNAs were translated and incorporated into native ribosomes locally in axons to maintain functionality of axonal ribosomes, which is required for local protein synthesis in response to stimulation and stress to axons. We also found that RP mRNAs were reduced in the pyramidal tract of sporadic ALS cases harboring TDP-43 pathology. Our results elucidated a novel function of TDP-43 to control transport of RP mRNAs and local translation by ribosomes to maintain morphological integrity of neuronal axons, and proved the influence of this function of TDP-43 on neurodegeneration in ALS and FTLD associated with TDP-43 proteinopathy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nagano</LastName><ForeName>Seiichi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Peripheral Nervous System Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan. nagano@neurol.med.osaka-u.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan. nagano@neurol.med.osaka-u.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jinno</LastName><ForeName>Junki</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdelhamid</LastName><ForeName>Rehab F</ForeName><Initials>RF</Initials><AffiliationInfo><Affiliation>Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Yinshi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, China-Japan Union Hospital of Jilin University, Jilin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shibata</LastName><ForeName>Megumi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Peripheral Nervous System Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watanabe</LastName><ForeName>Shohei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Peripheral Nervous System Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirokawa</LastName><ForeName>Sachiko</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Molecular Neuroscience, Brain Research Institute, Niigata University, Niigata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nishizawa</LastName><ForeName>Masatoyo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakimura</LastName><ForeName>Kenji</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cellular Neurobiology, Brain Research Institute, Niigata University, Niigata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Onodera</LastName><ForeName>Osamu</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okada</LastName><ForeName>Hironori</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okada</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Molecular and Medical Genetics, Center for Gene and Cell Therapy, Institute of Medical Science, University of Tokyo, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saito</LastName><ForeName>Yuko</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takahashi-Fujigasaki</LastName><ForeName>Junko</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neuropathology (Brain Bank for Aging Research), Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murayama</LastName><ForeName>Shigeo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neuropathology (Brain Bank for Aging Research), Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wakatsuki</LastName><ForeName>Shuji</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Peripheral Nervous System Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mochizuki</LastName><ForeName>Hideki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Araki</LastName><ForeName>Toshiyuki</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-3625-2042</Identifier><AffiliationInfo><Affiliation>Department of Peripheral Nervous System Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan. taraki@ncnp.go.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Acta Neuropathol</MedlineTA><NlmUniqueID>0412041</NlmUniqueID><ISSNLinking>0001-6322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012269">Ribosomal Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C578077">TDP-43 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001369" MajorTopicYN="N">Axons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014176" MajorTopicYN="N">Protein Biosynthesis</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021381" MajorTopicYN="N">Protein Transport</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012269" MajorTopicYN="N">Ribosomal Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057177" MajorTopicYN="N">TDP-43 Proteinopathies</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Local translation</Keyword><Keyword MajorTopicYN="N">Ribonucleic acid</Keyword><Keyword MajorTopicYN="N">Ribosome</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32803350</ArticleId><ArticleId IdType="doi">10.1007/s00401-020-02205-y</ArticleId><ArticleId IdType="pii">10.1007/s00401-020-02205-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Akashi K, Kakizaki T, Kamiya H, Fukaya M, Yamasaki M, Abe M et al (2009) NMDA receptor GluN2B (GluR epsilon 2/NR2B) subunit is crucial for channel function, postsynaptic macromolecular organization, and actin cytoskeleton at hippocampal CA3 synapses. J Neurosci 29:10869&#x2013;10882</Citation><ArticleIdList><ArticleId IdType="pubmed">19726645</ArticleId><ArticleId IdType="pmc">6665524</ArticleId></ArticleIdList></Reference><Reference><Citation>Alami NH, Smith RB, Carrasco MA, Williams LA, Winborn CS, Han SS et al (2014) Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron 81:536&#x2013;543</Citation><ArticleIdList><ArticleId IdType="pubmed">24507191</ArticleId><ArticleId IdType="pmc">3939050</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H et al (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351:602&#x2013;611</Citation><ArticleIdList><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Araki T, Milbrandt J (2003) ZNRF proteins constitute a family of presynaptic E3 ubiquitin ligases. J Neurosci 23:9385&#x2013;9394</Citation><ArticleIdList><ArticleId IdType="pubmed">14561866</ArticleId><ArticleId IdType="pmc">6740566</ArticleId></ArticleIdList></Reference><Reference><Citation>Araki T, Sasaki Y (2004) Milbrandt, J (2004) Increased nuclear NAD biosynthesis and Sir2 activation prevent axonal degeneration. Science 305:1010&#x2013;1013</Citation><ArticleIdList><ArticleId IdType="pubmed">15310905</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannai H, Fukatsu K, Mizutani A, Natsume T, Iemura S, Ikegami T et al (2004) An RNA-interacting protein, SYNCRIP (heterogeneous nuclear ribonuclear protein Q1/NSAP1) is a component of mRNA granule transported with inositol 1,4,5-trisphosphate receptor type 1 mRNA in neuronal dendrites. J Biol Chem 279:53427&#x2013;53434</Citation><ArticleIdList><ArticleId IdType="pubmed">15475564</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertrand E, Chartrand P, Schaefer M, Shenoy SM, Singer RH, Long RM (1998) Localization of ASH1 mRNA particles in living yeast. Mol Cell 2:437&#x2013;445</Citation><ArticleIdList><ArticleId IdType="pubmed">9809065</ArticleId></ArticleIdList></Reference><Reference><Citation>Caldarola S, De Stefano MC, Amaldi F, Loreni F (2009) Synthesis and function of ribosomal proteins&#x2013;fading models and new perspectives. Febs J 276:3199&#x2013;3210</Citation><ArticleIdList><ArticleId IdType="pubmed">19438715</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu J, Majumder P, Chatterjee B, Huang S, Shen CJ (2019) TDP-43 regulates coupled dendritic mRNA transport-translation processes in co-operation with FMRP and staufen1. Cell Rep 29:3118&#x2013;3133</Citation><ArticleIdList><ArticleId IdType="pubmed">31801077</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne AN, Siddegowda BB, Estes PS, Johannesmeyer J, Kovalik T, Daniel SG et al (2014) Futsch/MAP1B mRNA is a translational target of TDP-43 and is neuroprotective in a Drosophila model of amyotrophic lateral sclerosis. J Neurosci 34:15962&#x2013;15974</Citation><ArticleIdList><ArticleId IdType="pubmed">25429138</ArticleId><ArticleId IdType="pmc">4244467</ArticleId></ArticleIdList></Reference><Reference><Citation>Damgaard CK, Lykke-Andersen J (2011) Translational coregulation of 5'TOP mRNAs by TIA-1 and TIAR. Genes Dev 25:2057&#x2013;2068</Citation><ArticleIdList><ArticleId IdType="pubmed">21979918</ArticleId><ArticleId IdType="pmc">3197204</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn KW, Kamocka MM, McDonald JH (2011) A practical guide to evaluating colocalization in biological microscopy. Am J Physiol Cell Physiol 300:C723&#x2013;742</Citation><ArticleIdList><ArticleId IdType="pubmed">21209361</ArticleId><ArticleId IdType="pmc">3074624</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallini C, Bassell GJ, Rossoll W (2012) The ALS disease protein TDP-43 is actively transported in motor neuron axons and regulates axon outgrowth. Hum Mol Genet 21:3703&#x2013;3718</Citation><ArticleIdList><ArticleId IdType="pubmed">22641816</ArticleId><ArticleId IdType="pmc">3406762</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallini C, Donlin-Asp PG, Rouanet JP, Bassell GJ, Rossoll W (2016) Deficiency of the survival of motor neuron protein impairs mRNA localization and local translation in the growth cone of motor neurons. J Neurosci 36:3811&#x2013;3820</Citation><ArticleIdList><ArticleId IdType="pubmed">27030765</ArticleId><ArticleId IdType="pmc">4812137</ArticleId></ArticleIdList></Reference><Reference><Citation>Gazda HT, Preti M, Sheen MR, O'Donohue MF, Vlachos A, Davies SM et al (2012) Frameshift mutation in p53 regulator RPL26 is associated with multiple physical abnormalities and a specific pre-ribosomal RNA processing defect in diamond-blackfan anemia. Hum Mutat 33:1037&#x2013;1044</Citation><ArticleIdList><ArticleId IdType="pubmed">22431104</ArticleId><ArticleId IdType="pmc">3370062</ArticleId></ArticleIdList></Reference><Reference><Citation>Habuchi S, Tsutsui H, Kochaniak AB, Miyawaki A, van Oijen AM (2008) mKikGR, a monomeric photoswitchable fluorescent protein. PLoS ONE 3:e3944</Citation><ArticleIdList><ArticleId IdType="pubmed">19079591</ArticleId><ArticleId IdType="pmc">2592542</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton TL, Stoneley M, Spriggs KA, Bushell M (2006) TOPs and their regulation. Biochem Soc Trans 34:12&#x2013;16</Citation><ArticleIdList><ArticleId IdType="pubmed">16246169</ArticleId></ArticleIdList></Reference><Reference><Citation>Igaz LM, Kwong LK, Lee EB, Chen-Plotkin A, Swanson E, Unger T et al (2011) Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice. J Clin Invest 121:726&#x2013;738</Citation><ArticleIdList><ArticleId IdType="pubmed">21206091</ArticleId><ArticleId IdType="pmc">3026736</ArticleId></ArticleIdList></Reference><Reference><Citation>Iguchi Y, Katsuno M, Niwa J, Takagi S, Ishigaki S, Ikenaka K et al (2013) Loss of TDP-43 causes age-dependent progressive motor neuron degeneration. Brain 136:1371&#x2013;1382</Citation><ArticleIdList><ArticleId IdType="pubmed">23449777</ArticleId></ArticleIdList></Reference><Reference><Citation>Intine RV, Tenenbaum SA, Sakulich AL, Keene JD, Maraia RJ (2003) Differential phosphorylation and subcellular localization of La RNPs associated with precursor tRNAs and translation-related mRNAs. Mol Cell 12:1301&#x2013;1307</Citation><ArticleIdList><ArticleId IdType="pubmed">14636586</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishiguro A, Kimura N, Watanabe Y, Watanabe S, Ishihama A (2016) TDP-43 binds and transports G-quadruplex-containing mRNAs into neurites for local translation. Genes Cells 21:466&#x2013;481</Citation><ArticleIdList><ArticleId IdType="pubmed">26915990</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E, Lin L, Tradewell ML, Dion PA, Bercier V, Bourgouin P et al (2010) Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. Hum Mol Genet 19:671&#x2013;683</Citation><ArticleIdList><ArticleId IdType="pubmed">19959528</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, Vande Velde C et al (2008) TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 40:572&#x2013;574</Citation><ArticleIdList><ArticleId IdType="pubmed">18372902</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakegawa T, Ohuchi N, Hayakawa A, Hirata S, Matsuda M, Kogure K et al (2007) Identification of AUF1 as a rapamycin-responsive binding protein to the 5'-terminal oligopyrimidine element of mRNAs. Arch Biochem Biophys 465:274&#x2013;281</Citation><ArticleIdList><ArticleId IdType="pubmed">17603996</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawahara Y, Mieda-Sato A (2012) TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc Natl Acad Sci U S A 109:3347&#x2013;3352</Citation><ArticleIdList><ArticleId IdType="pubmed">22323604</ArticleId><ArticleId IdType="pmc">3295278</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelleher RJ 3rd, Govindarajan A, Tonegawa S (2004) Translational regulatory mechanisms in persistent forms of synaptic plasticity. Neuron 44:59&#x2013;73</Citation><ArticleIdList><ArticleId IdType="pubmed">15450160</ArticleId></ArticleIdList></Reference><Reference><Citation>Krichevsky AM, Kosik KS (2001) Neuronal RNA granules: a link between RNA localization and stimulation-dependent translation. Neuron 32:683&#x2013;696</Citation><ArticleIdList><ArticleId IdType="pubmed">11719208</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, Polymenidou M, Hutt KR, Vu AQ, Baughn M, Huelga SC et al (2012) Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat Neurosci 15:1488&#x2013;1497</Citation><ArticleIdList><ArticleId IdType="pubmed">23023293</ArticleId><ArticleId IdType="pmc">3586380</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling SC, Polymenidou M, Cleveland DW (2013) Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79:416&#x2013;438</Citation><ArticleIdList><ArticleId IdType="pubmed">23931993</ArticleId><ArticleId IdType="pmc">4411085</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu-Yesucevitz L, Bassell GJ, Gitler AD, Hart AC, Klann E, Richter JD et al (2011) Local RNA translation at the synapse and in disease. J Neurosci 31:16086&#x2013;16093</Citation><ArticleIdList><ArticleId IdType="pubmed">22072660</ArticleId><ArticleId IdType="pmc">3241995</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder P, Chu JF, Chatterjee B, Swamy KB, Shen CJ (2016) Co-regulation of mRNA translation by TDP-43 and Fragile X syndrome protein FMRP. Acta Neuropathol 132:721&#x2013;738</Citation><ArticleIdList><ArticleId IdType="pubmed">27518042</ArticleId><ArticleId IdType="pmc">5073124</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis AD, Naylor BC, Carson RH, Evans E, Harwell J, Knecht J et al (2017) Mechanisms of in vivo ribosome maintenance change in response to nutrient signals. Mol Cell Proteom 16:243&#x2013;254</Citation></Reference><Reference><Citation>Meyuhas O (2000) Synthesis of the translational apparatus is regulated at the translational level. Eur J Biochem 267:6321&#x2013;6330</Citation><ArticleIdList><ArticleId IdType="pubmed">11029573</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130&#x2013;133</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M, Lagier-Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY et al (2011) Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci 14:459&#x2013;468</Citation><ArticleIdList><ArticleId IdType="pubmed">21358643</ArticleId><ArticleId IdType="pmc">3094729</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu D, Parada P, Marcos AG, Cardenas D, Remacha M, Ballesta JP (2006) Different roles of P1 and P2 Saccharomyces cerevisiae ribosomal stalk proteins revealed by cross-linking. Mol Microbiol 62:1191&#x2013;1202</Citation><ArticleIdList><ArticleId IdType="pubmed">17040491</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A, Buratti E (2016) Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins. J Neurochem 138(Suppl 1):95&#x2013;111</Citation><ArticleIdList><ArticleId IdType="pubmed">27015757</ArticleId></ArticleIdList></Reference><Reference><Citation>Shigeoka T, Koppers M, Wong HHW, Lin JQ, Cagnetta R, Dwivedy A et al (2019) On-site ribosome remodeling by locally synthesized ribosomal protein in axons. Cell Rep 29:3605&#x2013;3619</Citation><ArticleIdList><ArticleId IdType="pubmed">31825839</ArticleId><ArticleId IdType="pmc">6915326</ArticleId></ArticleIdList></Reference><Reference><Citation>Slomnicki LP, Pietrzak M, Vashishta A, Jones J, Lynch N, Elliot S et al (2016) Requirement of neuronal ribosome synthesis for growth and maintenance of the dendritic tree. J Biol Chem 291:5721&#x2013;5739</Citation><ArticleIdList><ArticleId IdType="pubmed">26757818</ArticleId><ArticleId IdType="pmc">4786710</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith BN, Ticozzi N, Fallini C, Gkazi AS, Topp S, Kenna KP et al (2014) Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS. Neuron 84:324&#x2013;331</Citation><ArticleIdList><ArticleId IdType="pubmed">25374358</ArticleId><ArticleId IdType="pmc">4521390</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B et al (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319:1668&#x2013;1672</Citation><ArticleIdList><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarup V, Phaneuf D, Bareil C, Robertson J, Rouleau GA, Kriz J et al (2011) Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments. Brain 134:2610&#x2013;2626</Citation><ArticleIdList><ArticleId IdType="pubmed">21752789</ArticleId></ArticleIdList></Reference><Reference><Citation>Tollervey JR, Curk T, Rogelj B, Briese M, Cereda M, Kayikci M et al (2011) Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat Neurosci 14:452&#x2013;458</Citation><ArticleIdList><ArticleId IdType="pubmed">21358640</ArticleId><ArticleId IdType="pmc">3108889</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomono T, Hirai Y, Okada H, Adachi K, Ishii A, Shimada T et al (2016) Ultracentrifugation-free chromatography-mediated large-scale purification of recombinant adeno-associated virus serotype 1 (rAAV1). Mol Ther Methods Clin Dev 3:15058</Citation><ArticleIdList><ArticleId IdType="pubmed">26913289</ArticleId><ArticleId IdType="pmc">4748944</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi VB, Baskaran P, Shaw CE, Guthrie S (2014) Tar DNA-binding protein-43 (TDP-43) regulates axon growth in vitro and in vivo. Neurobiol Dis 65:25&#x2013;34</Citation><ArticleIdList><ArticleId IdType="pubmed">24423647</ArticleId><ArticleId IdType="pmc">3988849</ArticleId></ArticleIdList></Reference><Reference><Citation>Twiss JL, Fainzilber M (2009) Ribosomes in axons&#x2013;scrounging from the neighbors? Trends Cell Biol 19:236&#x2013;243</Citation><ArticleIdList><ArticleId IdType="pubmed">19359177</ArticleId></ArticleIdList></Reference><Reference><Citation>van Niekerk EA, Willis DE, Chang JH, Reumann K, Heise T, Twiss JL (2007) Sumoylation in axons triggers retrograde transport of the RNA-binding protein La. Proc Natl Acad Sci U S A 104:12913&#x2013;12918</Citation><ArticleIdList><ArticleId IdType="pubmed">17646655</ArticleId><ArticleId IdType="pmc">1937566</ArticleId></ArticleIdList></Reference><Reference><Citation>Villarreal J Jr, Lee JC (1998) Yeast ribosomal protein L26 is located at the ribosomal subunit interface as determined by chemical cross-linking. Biochimie 80:321&#x2013;324</Citation><ArticleIdList><ArticleId IdType="pubmed">9672752</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakatsuki S, Furuno A, Ohshima M, Araki T (2015) Oxidative stress-dependent phosphorylation activates ZNRF1 to induce neuronal/axonal degeneration. J Cell Biol 211:881&#x2013;896</Citation><ArticleIdList><ArticleId IdType="pubmed">26572622</ArticleId><ArticleId IdType="pmc">4657170</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegorzewska I, Bell S, Cairns NJ, Miller TM, Baloh RH (2009) TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A 106:18809&#x2013;18814</Citation><ArticleIdList><ArticleId IdType="pubmed">19833869</ArticleId><ArticleId IdType="pmc">2762420</ArticleId></ArticleIdList></Reference><Reference><Citation>Wils H, Kleinberger G, Janssens J, Pereson S, Joris G, Cuijt I et al (2010) TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A 107:3858&#x2013;3863</Citation><ArticleIdList><ArticleId IdType="pubmed">20133711</ArticleId><ArticleId IdType="pmc">2840518</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu LS, Cheng WC, Shen CK (2012) Targeted depletion of TDP-43 expression in the spinal cord motor neurons leads to the development of amyotrophic lateral sclerosis-like phenotypes in mice. J Biol Chem 287:27335&#x2013;27344</Citation><ArticleIdList><ArticleId IdType="pubmed">22718760</ArticleId><ArticleId IdType="pmc">3431639</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu YF, Gendron TF, Zhang YJ, Lin WL, D'Alton S, Sheng H et al (2010) Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J Neurosci 30:10851&#x2013;10859</Citation><ArticleIdList><ArticleId IdType="pubmed">20702714</ArticleId><ArticleId IdType="pmc">3056148</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokoseki A, Shiga A, Tan CF, Tagawa A, Kaneko H, Koyama A et al (2008) TDP-43 mutation in familial amyotrophic lateral sclerosis. Ann Neurol 63:538&#x2013;542</Citation><ArticleIdList><ArticleId IdType="pubmed">18438952</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon BC, Jung H, Dwivedy A, O'Hare CM, Zivraj KH, Holt CE (2012) Local translation of extranuclear lamin B promotes axon maintenance. Cell 148:752&#x2013;764</Citation><ArticleIdList><ArticleId IdType="pubmed">22341447</ArticleId><ArticleId IdType="pmc">3314965</ArticleId></ArticleIdList></Reference><Reference><Citation>Zivraj KH, Tung YC, Piper M, Gumy L, Fawcett JW, Yeo GS et al (2010) Subcellular profiling reveals distinct and developmentally regulated repertoire of growth cone mRNAs. J Neurosci 30:15464&#x2013;15478</Citation><ArticleIdList><ArticleId IdType="pubmed">21084603</ArticleId><ArticleId IdType="pmc">3683943</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>